XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Operating activities:              
Net loss $ 453 $ (3,993) $ (60,630) $ (1,054) $ (13,032) $ (63,392)  
Adjustments to reconcile net loss to net cash provided by operating activities:              
Depreciation         17,650 16,194  
Unrealized foreign currency loss         4,788 0  
Non-cash operating lease expense         3,744 4,031  
Stock-based compensation expense         2,863 2,267  
Amortization expense of finance leases         2,794 2,691  
Amortization of intangible assets 633   764   1,897 2,365  
Deferred tax provision (benefit)         520 (2,182)  
Impairment of goodwill 0   63,000   0 63,000 $ 63,000
Impairment of right-of-use and long-lived assets 0   1,397   0 1,397  
Other         1,984 947  
Changes in operating assets and liabilities:              
Accounts receivable         13,990 8,399  
Prepaid expenses and other assets         504 4,722  
Accounts payable, accrued expenses and other liabilities         (3,214) 588  
Contract liabilities and customer advances         (8,454) (6,172)  
Operating lease liabilities         (6,545) (6,715)  
Net cash provided by operating activities         19,489 28,140  
Investing activities:              
Capitalized internal-use software costs         (16,757) (18,189)  
Purchases of property and equipment         (649) (579)  
Net cash used in investing activities         (17,406) (18,768)  
Financing activities:              
Principal payments on finance leases         (2,978) (2,172)  
Principal payments on insurance financing         (1,796) 0  
Contingent consideration payment at initial value         (859) (3,704)  
Payment of financing and debt issuance costs         (559) 0  
Principal payments of term loan         (338) 0  
Payments of line of credit         0 (6,000)  
Other         (6) (266)  
Net cash used in financing activities         (6,536) (12,142)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash         868 19  
Net decrease in cash, cash equivalents and restricted cash         (3,585) (2,751)  
Cash, cash equivalents and restricted cash at beginning of period   $ 33,468   $ 22,936 33,468 22,936 22,936
Cash, cash equivalents and restricted cash at end of period 29,883   20,185   29,883 20,185 33,468
Cash and cash equivalents 26,705   19,996   26,705 19,996 29,937
Restricted cash 3,178   189   3,178 189 3,531
Total cash, cash equivalents and restricted cash $ 29,883   $ 20,185   29,883 20,185 $ 33,468
Supplemental cash flow disclosure:              
Cash paid for interest on debt, net of amounts capitalized (1) [1]         3,938 923  
Supplemental disclosures of non-cash investing and financing activities:              
Convertible redeemable preferred stock dividends accrued but not yet paid (related parties)         13,904 4,424  
Right-of-use assets obtained in exchange for finance lease liabilities         619 7,861  
Settlement of restricted stock unit liability         314 1,895  
Issuance of convertible redeemable preferred stock (related parties) [2]         $ 0 $ 32,771  
[1] For the nine months ended September 30, 2025, cash paid for interest on debt reflects the interest paid on the Company's senior secured financing agreement with Blue Torch Finance LLC. For the nine months ended September 30, 2024 cash paid for interest on debt reflects the interest paid on the Company's prior credit agreement with Bank of America N.A.
[2] The preferred stock issuance was initially recognized at fair value. The Company recorded the initial fair value, net of issuance costs, of $19.6 million within mezzanine equity and the remaining $13.0 million within additional paid-in capital on the Condensed Consolidated Balance Sheet as of September 30, 2024. Refer to Footnote 5, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit)